Jagsonpal Pharmaceuticals Limited (BOM:507789)
221.55
-1.60 (-0.72%)
At close: Jul 21, 2026
Jagsonpal Pharmaceuticals Market Cap
Jagsonpal Pharmaceuticals has a market cap or net worth of 14.97 billion as of July 21, 2026. Its market cap has decreased by -11.46% in one year.
Market Cap
14.97B
Enterprise Value
13.99B
Revenue
2.87B
Ranking
n/a
PE Ratio
34.76
Stock Price
221.55
ChartMarket Cap Chart
Since March 1, 2000, Jagsonpal Pharmaceuticals's market cap has decreased from 17.63B to 14.97B, a decrease of -15.07%. That is a compound annual growth rate of -0.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 14.91B | 15.91% |
| Dec 31, 2025 | 12.86B | -20.68% |
| Dec 31, 2024 | 16.22B | 58.61% |
| Dec 29, 2023 | 10.22B | 4.69% |
| Dec 30, 2022 | 9.77B | 108.36% |
| Dec 31, 2021 | 4.69B | 150.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Suven Life Sciences | 89.35B |
| IOL Chemicals and Pharmaceuticals | 45.61B |
| Gujarat Themis Biosyn | 39.71B |
| Sai Parenteral's | 24.71B |
| NGL Fine-Chem | 18.58B |
| Bajaj HealthCare | 12.95B |
| Shree Ganesh Remedies | 8.27B |
| Anlon Healthcare | 7.97B |